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After Epstein-Barr virus superinfection of the human lymphoblastoid cell line
Raji, a Burkitt lymphoma-derived line that contains Epstein-Barr virus genomes
in an episomal form, at least 40 polypeptides could be resolved by polyacrylamide
gel electrophoresis. Eleven of the 40 polypeptides were immunoprecipitable by
early antigen'/viral capsid antigen' antiserum. The polypeptides could be divided
into six classes, immediate-early, early, intermediate, late, very late, and persist-
ent, depending upon the time of synthesis. Ten of the 40 polypeptides appeared
to preexist before superinfection and persisted despite general cessation of host
protein synthesis; none of the persistent proteins was immunoprecipitated by the
Epstein-Barr virus antibody-containing serum. When viral DNA replication was
blocked by a variety of inhibitors of DNA synthesis, a number of different
patterns of polypeptide synthesis could be detected. The synthesis of six polypep-
tides was blocked by the most virus-specific inhibitors, acyclovir and phospho-
noacetic acid. Additionally, in the presence of 1-,8-D-arabinofuranosylcytosine, 1-
,8-D-arabinofuranosyladenine, and methotrexate, seven polypeptides showed ov-
ersynthesis.
Although infection with Epstein-Barr virus
(EBV) is universal, expression of the several
diseases associated with EBV infection is infre-
quent (19). The manifestations of infection may,
in part, be determined by host cellular factors
(7) which it should eventually be possible to
relate to specific polypeptides induced in EBV-
infected cells. We (6) and others (1, 2, 15, 17)
have begun to decipher the patterns of polypep-
tide synthesis that arise in a partially permissive
system, superinfection of Raji cells with EBV
(27). To accompany these analyses and add to
an emerging pattern of orderly polypeptide syn-
thesis, we have studied the effects of inhibitors
of DNA synthesis on protein synthesis in Raji
cells superinfected with EBV. With concentra-
tions of various inhibitors of DNA replication
that interfere primarily with viral DNA synthe-
sis (4, 5, 16, 24), we find that only 6 of the 40
polypeptides induced by superinfection exhibit
dependence on viral DNA replication with clear
reduction of their synthesis. Seven other poly-
peptides are affected differently, showing over-
synthesis. It is not yet clear whether the excess
synthesis of these seven polypeptides, which are
synthesized relatively early after infection, is a
consequence of the inhibition of the other six
polypeptides which are made relatively late or
is due directly to blockage ofDNA synthesis. In
any case these studies have made it possible to
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delineate a new class of EBV-induced polypep-
tides, tentatively designated immediate-early, in
addition to the early, intermediate, late, and
persistent classes that we described previously.
MATERIALS AND METHODS
Cells and virus. The two Burkitt lymphoma-de-
rived cell lines, Raji and P3HR-1, were maintained at
37°C as described previously (21). Extracellular virus
was purified from P3HR-1 cells 10 days after addition
of 12-O-tetradecanoyl-phorbol-13-acetate at a concen-
tration of 20 ng/ml (13, 29!
Radiolabeling of virus-induced proteins. Cells
were either labeled continuously or pulse-labeled with
[3S]methionine as described previously (6).
Gel electrophoresis. Slab gel electrophoresis in
7.5% polyacrylamide gels, using the method of Laem-
mli (12), was described previously. Gels were prepared
for fluorography by the method of Bonner and Laskey
(3) and exposed at -70°C. Determination of protein
concentration was by the method of Lowry et al. (14).
Polypeptide molecular weights were determined with
molecular-weight standards (26).
Immunoprecipitation. Extracts from infected and
mock-infected extracts were immunoprecipitated by
the method of Kessler (11) with EBV early antigen'/
viral capsid antigen' (EA+/VCA+) antiserum (titers,
320/640).
Inhibition of viral DNA replication. The drugs
acyclovir [ACV; 9-(2-hydroxyethoxymethyl)guanine],
phosphonoacetic acid (PAA), hydroxyurea, 1-f3-D-ar-
abinofuranosylcytosine (araC), 1-fi-D-arabinofurano-
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syladenine (araA), methotrexate (MTX), fluorodeox-
yuridine (FUdR), and novobiocin (NVB) were added
to the cells after a 2-h absorption of virus to cells. The
final concentrations were: ACV, 100,uM; PAA, 100,ug/
ml; hydroxyurea, 10 mM; araC, 50,ug/ml; araA, 50 jLg/
ml; MTX, 10 [LM; FUdR, 10 uM; NVB, 100 ytM. After
radiolabeling, cell pellets were solubilized and sub-
jected to electrophoresis.
Labeling ofDNA in the presence and absence
of inhibitors. Raji cells (107) were infected initially
with 3 ml of stock virus as described above. After
absorption for 2 h the cells were divided into aliquots
containing 106 cells and diluted with 10 ml of media
(RPMI 1640, 5% fetal calf serum, penicillin, and strep-
tomycin; see above) with or without inhibitors as
described above and incubated at 37°C for an addi-
tional 2 h. At this time, [3H]thymidine (Schwarz/
Mann; specific activity, 40 to 60 Ci/mmol) was added
to each culture at a final concentration of 10 LCi/ml,
and the cells were incubated at 370C for an additional
20 h. The cells were then harvested by low-speed
centrifugation, washed with cold phosphate-buffered
saline solution (0.01 M phosphate buffer [pH 7.4],0.15
M NaCl), and stored at -70°C. Mock-infected Raji
cells in media containing inhibitors were treated iden-
tically to controls.
Density analysis ofDNA. [3H]Thymidine-labeled
Raji cells treated with inhibitor and untreated were
suspended in TE buffer (10 mM Tris-hydrochloride, 1
mM EDTA [pH 7.5]) and lysed by the addition of
Sarkosyl (final concentration, 0.5%) followed by incu-
bation at 370C for 30 min. CsCl was added to give a
mean density of 1.710 g/ml in a total volume of 8 ml,
and the solutions were centrifuged at 36,000 rpm for
48 h in a Beckman L3-50 ultracentrifuge in a type 65
rotor. The gradients were fractionated from the bot-
tom into 0.2-ml fractions, which were assayed in a
liquid scintillation counter with a Triton-toluene base
fluor.
Chemicals. 12-O-Tetradecanoyl-phorbol-13-ace-
tate was purchased from Sigma Chemical Co., PAA
was from Richmond Organics, and radiolabeled com-
pounds were from New England Nuclear Corp.
RESULTS
Polypeptides synthesized after superin-
fection of Raji cells with EBV. Table 1 sum-
marizes the polypeptides identified in our pre-
vious report (6) and includes those polypeptides
identified here. The earlier listing has been mod-
ified slightly as a result of the data obtained in
this work.
Multiplicity of infection. For reproducibil-
ity of results, serial twofold dilutions were car-
ried out to arrive at optimum infectivity as
gauged by the induction of the complete set of
polypeptides. The virus was prepared from the
producer cell line, P3HR-1, induced by 12-
O-tetradecanoyl-phorbol-13-acetate. Figure 1
shows the effect of virus dilution on protein
induction in superinfected Raji cells which were
labeled from 6 to 24 h after infection. Polypep-
TABLE 1. Polypeptides synthesized in Raji cells
after superinfection by EBV
Poly- Mol Pl MolPolY- Class' wt PolY- Class wt
peptide (xl10') peptide (X10')
A VL 170 14 L 86
O VL 165 15 P 78
OA VL 160 16 E 75
1 I 155 17 P 72
2 I 145 10 L 68
2A L 142 19 IE 62
3 E 140 20 P 58
3A L 135 21 L 56
4 E 125 22 P 52
5 L 123 23 P 50
6 L 122 24 IE 48
7 P 121 25 P 41
7A IE 117 26 E 30
8 L 116 27 E 26
9 P 115 28 L 25
10 L 110 28A L 24
IOAb E 105 28B P 23
liE E 100 28C P 22.5
11A E 98 28D L 22
12 L 95 29 L 21
13 L 92
aIE, Immediate-early; E, early; I, intermediate; L,
late; VL, very late; P, persistent.
b Polypeptide 10A is seen only in the presence of
ACV and PAA.
tides 1, 2, 3, 4, and 11 were the prime indicators;
the highest dilution of virus which strongly in-
duced these polypeptides was used for all of the
following experiments. The protein pattern in
lane C was considered optimal. The amount of
250-fold-concentrated virus needed to produce
this pattern varied from 0.5 to 0.025 ml/106 cells.
The variation in infectivity is a function of the
producer cell line, P3HR-1, rather than of the
Raji cells. Pooled virus from a batch of P3HR-1
cells yielded the same multiplicity of infection
with Raji cells after storage for >6 months at
-70°C. We avoided use of lower dilutions in
order to miniimize high multiplicity effects such
as generation of defective virus. Each pool of
virus was checked in this way, and for these
studies this index gave more consistent results
than did other indices such as EA induction.
Immunoprecipitation of virus-induced
polypeptides. To determine the possible viral
origin of the polypeptides synthesized after in-
fection, proteins extracted from superinfected
Raji cells after continuous labeling 10 to 24 h
postinfection were immunoprecipitated with
EA+/VCA+ serum. This treatment specifically
precipitated 10 to 13 polypeptides of the 40
detected by radiolabeling after superinfection.
Ten of these polypeptides were consistently
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FIG. 1. Multiplicity of infection. Raji cells were
superinfected with P3HR-1 virus in serial twofold
dilutions. The virus was concentrated 250 times as
described in the text. (A) Cells were infected with 0.5
ml of virus; (B) 0.25 ml; (C) 0.125 ml, etc., in a total
volume of 0.5 ml. (H) Mock-infected. Numbers on left
refer to virus-inducedpolypeptides; numbers on right
refer to molecular-weight markers.
fications and numeric designations (which cor--
respond to those used previously) of the immu-
noprecipitated polypeptides are summarized in
Table 2. There is a variation in the number of
polypeptides that appear-as minor bands in the
gels of the precipitates. This variation is due in
part to non-specific trapping of polypeptides;
also, synthesis at a low level of some induced
polypeptides may be sensitive to multiplicity of
infection effects. Such minor bands could be
detected by longer exposures which led, how-
ever, to detection of a greater number of host
proteins in the mock-infected cells. Additionally,
there was some variation in the sera used. We
focused on 10 bands that were consistently pres-
ent with several sera and seemed to be major
immunoprecipitable polypeptides. Additional
polypeptides were undoubtedly virus coded, but
not precipitated by EA+/VCA+ serum.
29
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FIG. 2. Immunoprecipitation ofpolypeptides from
mock-infected (A) and superinfected cells (B). Raji
cells were infected and labeled as described in the
test. The labeled polypeptides were extracted and
immunoprecipitated with EA+/VCA+ antisera. Num-
bers correspond to virus-induced polypeptides.
Effect of inhibitors ofDNA synthesis. To
determine whether the synthesis of any of the
EBV-induced polypeptides is dependent on ac-
tive DNA synthesis, particularly viral, we se-
lected concentrations of a variety of inhibitors
that would be expected to have a minimal effect
on host DNA synthesis, but an appreciable effect
on viral DNA synthesis. Some of the inhibitors
were almost totally virus specific; also, we se-
lected inhibitors that have different modes of
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viral and host DNA are indicated in Table 3.
These figures are necessarily somewhat impre-
cise because they were derived from DNA den-
sity measurements. Concentrations of inhibitors
were selected which inhibited host-DNA repli-
cation by not more than about 10%, except for
araC. The drug araC was fairly toxic for the
cells, but the concentration of the drug used did
not adversely affect cell growth. In the infected
cells, viral DNA synthesis ranged from <3% to
80% of the control. The inhibitors ACV, PAA,
hydroxyurea, araC, and araA were strongly in-
TABLE 2. Immunoprecipitation and oversynthesis
of virus-induced polypeptides
Irnmuno- Oversynthesis in
precipita- presence of araC,
C1 Polypep- tion by araA, and MTX
tide EA-/
VCA+an- llh 16h 24h
tiserum
Immediate- 7A - + +
early 19 - + ±
24 - + + -
Early 3 + - + +
4 + - _
11 + - + +
11A + - + +
16 - - + -
26 + - - -
27 + - - -
Intermedi- 1 + - -
ate 2 + - -
Late 14 + - -
18 + - - _
29 + - -
TABLE 3. Effect of various inhibitors on DNA
synthesis in superinfected (SI) and mock-infected
(MI) Raji cellsa
% EBV %DNA
DNA syn-syteiInhibitor Concn thesis in synthesisSIRiniIRjSI Raji cnellsJicells cels
Control 100 100
ACV 100,uM 5 90
AraA 50 jg/ml 5 100
AraC 50 jug/ml 5 40
HUc 10mM 15 90
MTX 10 ,uM 40 95
PAA 100 ,g/ml 15 90
NVB 100,M 75 85
FUdR 10,uM 80 90
aCells were infected as described in the text.
bPercent DNA synthesis was determined as de-
scribed in the text.
c HU, Hydroxyurea.
J. VIROL.
hibitory of viral DNA replication. MTX showed
60% inhibition, whereas NVB and FUdR were
only slightly inhibitory. The degree of inhibition
varied in experiments by ±5%.
Effects ofDNA inhibitors on polypeptide
synthesis in mock-infected cells. The con-
centrations of inhibitors of DNA synthesis used
were directed primarily at viral DNA synthesis;
we examined the effects of these drugs on poly-
peptide synthesis in mock-infected, drug-treated
cells. Under conditions of both long-term label-
ing and pulse-labeling we could see no significant
difference in the polypeptides synthesized in any
of the treated cells. Figure 3 shows the polypep-
tide banding pattern obtained 24 h after mock
infection. The addition of araC led to a decrease
in the total amount of label incorporated; how-
ever, selective inhibition of polypeptides was not
detected.
Effect of DNA inhibitors on viral poly-
peptide synthesis. Superinfected Raji cells la-
beled continuously from 10 to 24 h postinfection
-68
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FIG. 3. Effect of inhibitors ofDNA replication on
synthesis ofpolypeptides in mock-infected Raji cells.
(A) No inhibitor; (B) ACV (100uM); (C) PAA (100 g/
ml); (D) hydroxyurea (10 mM); (E) araC (50 ug/ml);
(G) MTX (10 uM); (H) FUdR (10 IM); (I) NVB (100
pM). Numbers refer to molecular weight markers.
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in the presence of DNA inhibitors showed dis-
similar patterns of polypeptide synthesis (Fig.
4). We have now identified six polypeptides (Ta-
ble 4) that are clearly inhibited by the most
specific of the inhibitors of viral DNA synthesis,
ACV and PAA. The gel patterns obtained when
cells are continuously labeled demonstrated the
variability found with the different inhibitors.
However, due to the incomplete shutoff of host
protein synthesis, inhibition ofsome ofthe virus-
induced polypeptides was most clearly seen with
pulse-labeling (see below). Of interest is the ob-
servation that other DNA inhibitors ordinarily
thought to be relatively nonspecific, such as
hydroxyurea and MTX, inhibit the synthesis of
the same polypeptides. This similarity is proba-
bly in part a consequence ofthe dosages selected.
A B C D E F G H
FIG. 4. Effect of inhibitors ofDNA replication on
synthesis ofpolypeptides in superinfected Raji cells.
Cells were labeled continuously from 9 to 24 h after
infection as described in the text. (A) No inhibitor;
(B) ACV (100 LM); (C), PAA (100 pg/ml); (D) hydroxy-
urea (10 mM); (E) araC (50 pg/ml); (F) MTX (10 pM);
(G) FUdR (10 WM); (H) NVB (100 pM). Numbers refer
to virus-induced polypeptides.
The drug araC was broadly inhibitory; the
synthesis ofmany late polypeptides was strongly
inhibited, including five of the six inhibited by
ACV. In contrast, FUdR inhibited only three of
the polypeptides (10, 21, and 28) affected by
ACV. NVB gave a pattern of inhibition quite
different from that produced by the other inhib-
itors.
Polypeptides synthesized 6 h postinfec-
tion. In our previous report (6) we classified the
proteins synthesized in superinfected Raji cells
into four groups. Persistent polypeptides were
those with analogous bands in mock-infected
cells that were synthesized throughout infection.
The other classes were early polypeptides, syn-
thesized as early as 6 h postinfection, and late
polypeptides, appearing no sooner than 12 h
after infection. Through the use of the DNA
inhibitors at least one new class can be detected,
tentatively designated as immediate-early. This
class includes two polypeptides previously iden-
tified as early, 19 and 24, and one not resolved
before, 7A.
Some polypeptides not previously detected
can now be resolved; these are designated by
letters following the number of the next largest
polypeptide, e.g., 7A, with a molecular weight of
117,000. The immediate-early polypeptides are
not immunoprecipitated by VCA+/EA+ sera, but
are classified as virus induced due to the action
of several of the inhibitors on their synthesis.
The drugs araC, araA, and MTX cause clear
oversynthesis of the immediate-early polypep-
tides at 11 h postinfection, as discussed below.
At 6 h postinfection both immediate-early (3)
and early (7) proteins were detected (Table 2).
Host protein synthesis is continuing, and there
is an elevation in total protein synthesis (6). The
inhibitors of virus DNA synthesis had no effect
on virus-induced polypeptides (Fig. 5A) at this
time. All early proteins were synthesized in nor-
mal amounts. Persistent proteins also were not
inhibited. The high background of host protein
synthesis and the inability to immunoprecipitate
immediate-early virus-induced proteins hinder
further interpretation of the results.
Polypeptides synthesized 11 h postinfec-
tion. At 11 h postinfection, few of the late poly-
peptides were being synthesized in appreciable
amounts. The effect of the inhibitors was not yet
pronounced enough to be clear. The drugs araC,
araA, and MTX showed some inhibition of poly-
peptides 1, 2, 5, 14, 26, 28A, and 28D (Fig. 5B).
More striking was the evident oversynthesis of
the three immediate-early polypeptides 7A, 19,
and 24 in the presence of araC, araA, and MTX.
Finally, at 11 h an additional polypeptide,
1OA, was resolved in the presence of ACV and,
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TABLE 4. Effect of inhibitors ofDNA synthesis on inhibition ofprotein synthesis in superinfected Raji cells
InhibitorbPolypeptide
(class)' ACV PAA HU AraC MTX FUdR NVB
1 (I) 0 0 0 0 0 0
2 (I) 0 0 0 0
3A (L) 0 *
5 (L) 11 h
6 (L) 0 0 0 0*
8 (L)
10 (L) 0 0 0 0 *
12 (L) * 0 0 * S
13 (L) 16, 24h 16, 24h
14 (L) 0 0
16 (E)
18 (L) 0
21 (L) 0 0 0 0 0
26 (E) 11,16h 11 h
28 (L) 0 0 16 h * S
28A (L) 11 h 11 h
28D (L) llh llh
29 (L) 0 0
a Kinetic class of protein: E, early; I, intermediate; L, late.
b Concentration of inhibitor: ACV, 100 ,uM; PAA, 100 ,ug/ml; hydroxyurea (HU), 10 mM; araC, 50 ,tg/ml;
MTX, 10 ,uM; FUdR, 10 ,uM; and NVB, 100 t,M. Symbols: 0, partial inhibition of polypeptide synthesis; 0,
complete inhibition; 11, 16, and 24 h, inhibition detected with 35S-pulse at indicated time.
less clearly, in the presence of PAA (Fig. 5B).
Other minor differences can be detected in the
gel patterns. Table 4 summarizes the data ob-
tained with the inhibitors.
Proteins synthesized 16 h postinfection.
By the time that late protein synthesis is well
under way, there is clear inhibition of the syn-
thesis of most of the polypeptides affected by
the DNA inhibitors. Synthesis ofthe immediate-
early polypeptides continued in the cells treated
with araC, araA, and MTX. Additionally, there
is evidence of oversynthesis of the early proteins
3, 7A, 11, 16, and 24 (Fig. 5C, slots E, F, and G)
in the presence of araC, araA, and MTX. At this
point there is sharp inhibition of synthesis of
several of the polypeptides previously shown by
continuous labeling to be inhibited. These in-
clude polypeptides 1 and 2, which are suppressed
by all the inhibitors except MTX, FUdR, and
NVB. Polypeptide 6 is inhibited by ACV and
PAA. Polypeptides 13 and 14 are inhibited by
araC and araA, but only 13 appears to be in-
hibited by NVB. Synthesis of polypeptides 18,
26, and 28A is inhibited by araC and araA.
Proteins synthesized 24 h postinfection.
At 24 h postinfection, synthesis of early polypep-
tides 3, 4, 11, 16, and 19 was much reduced.
Polypeptides 0 and 2A are discernible in infected
cells (Fig. 5D). These proteins were not identi-
fied previously because of the low level of syn-
thesis of polypeptide 0 and the close migration
of 2A with 3.
This time point provided the clearest blockage
of synthesis of polypeptides by the virus-specific
inhibitors ACV and PAA: polypeptides 1, 2, and
6 were not visible. Additionally, the synthesis of
early polypeptides 3 and 11 seemed to be ter-
minated sooner in ACV- and PAA-treated cells.
Cells treated with araC and araA showed over-
production of the early polypeptides 3 and 11
(Fig. 5D, E, and F). These polypeptides are
distinct from the immediate-early proteins, the
oversynthesis of which occurred earlier (Table
2). Neither ACV nor PAA caused oversynthesis
of any of the polypeptides, including immediate-
early and early. There was also inhibition of the
synthesis of the same polypeptides as at 16 h in
the presence of the inhibitors. Finally, NVB
seemed to inhibit selectively a single polypep-
tide, 3A.
Protein synthesis at 36 h postinfection.
At 36 h postinfection, protein synthesis was very
low due to cell death. The polypeptide profiles
were similar in all of the treated cells. Polypep-
tide 2 was present only in the untreated and
NVB-treated cells (Fig. 6A). Polypeptides 2A
and 3A were specifically blocked in NVB-treated
cells. Polypeptide 6 was blocked by araC, araA,
MTX, and NVB. Oversynthesis of the early
polypeptide 19 was evident in araC-treated cells.
Protein synthesis at 48 h postinfection.
At 48 h postinfection, the gel patterns were
identical in all of the infected cell extracts (Fig.
6B), with more proteins ofhigh molecular weight
detected. These polypeptides were either very
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FIG. 5. Effects of inhibitors on virus polypeptide synthesis when cells are pulse-labeled for 30 min. The
inhibitors and concentrations are the same as in Fig. 3. Numbers refer to virus-inducedpolypeptides. (A) 6 h;
(B) 1I h; (C) 16 h; (D) 24 h.
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FIG. 6. Effects of inhibitors on virus polypeptide synthesis when cells are pulse-labeled for 30 min late after
infection. The inhibitors and concentrations are the same as in Fig. 3. Numbers refer to virus-induced
polypeptides. (A) 36 h, (B) 48 h.
which arose due to cell death. High rates of cell
death with araC and NVB treatment and exces-
sive exposure time make the results difficult to
interpret. The polypeptide banding patterns do
not disclose differences related to treatment with
the inhibitors.
DISCUSSION
The effects of inhibition of viral DNA repli-
cation on protein synthesis in EBV-infected cells
indicate that a complex mechanism for the reg-
ulation of synthesis of viral proteins exists. The
early class of polypeptides, of which all except
two (7A and 11A) were identified previously (6),
can now be subdivided into immediate-early and
early classes. The immediate-early class is ten-
tatively defined as those three polypeptides for-
merly classified as early which show prolonged
synthesis in infected cells treated with araC,
araA, or MTX. The immediate-early polypep-
tides (Table 2) reach maximum synthesis about
6 h after infection, before inhibition of host
protein synthesis, and are for the most part no
longer detectable 11 h after infection. Interest-
ingly, in both cytomegalovirus (23)- and herpes
simplex virus (20)-infected cells, three immedi-
ate-early polypeptides are detected; they are
defined by different criteria; viz., they are poly-
peptides, transcription for which occurs at the
earliest time after infection and in the presence
of cycloheximide. Upon removal of the cyclohex-
imide block immediate synthesis of these poly-
peptides occurs. The molecular weights are dif-
ferent, and there is no reported oversynthesis in
the presence of araC. The classification imme-
diate-early is a working definition since it is not
yet clear whether these polypeptides play any
regulatory role in the synthesis of later protein
classes.
The early class of polypeptides demonstrates
maximum synthesis between 9 and 11 h. The
synthesis of this class coincides with the inhibi-
tion of host protein synthesis and decreased
synthesis of immediate-early polypeptides and
decreases by 16 h after infection. At least three
of the polypeptides in the early class (3, 4, and





from lysates of both superinfected Raji cells and
BJAB cells acutely infected with EBV (R. J.
Feighny, B. E. Henry II, and J. S. Pagano,
submitted for publication). These polypeptides
are probably components of the EA complex
since infected BJAB cells express only EA and
not VCA; viral DNA replication does not take
place in BJAB cells. Mueller-Lantzsch et al. (17)
have identified two polypeptides, P35 and P85,
as components of the EA complex by immuno-
precipitation. Two of the immunoprecipitable
early polypeptides (3 and 11) show prolonged
synthesis in the presence of araC, araA, and
MTX. The increased synthesis of these EA-as-
sociated proteins caused by the inhibitors is
reminiscent of the enhancement ofEA induction
in the presence of araC in 12-0-tetradecanoyl-
phorbol-13-acetate-treated P3HR-1 cells (28).
The two intermediate polypeptides (1 and 2)
are initially detected at 9 to 11 h (6) and attain
maximum synthesis around 16 h after infection.
The synthesis of polypeptide 1 may precede that
of polypeptide 2. At 11 h after infection polypep-
tide 1 appears to be present in slightly greater
amounts than 2, whereas by 16 and 24 h after
infection polypeptide 2 is more predominant
than 1. Polypeptide 1 also shows less sensitivity
to the DNA replication inhibitors, its synthesis
being only partially blocked by ACV, PAA, hy-
droxyurea, and MTX, and as reported by others
(17), it is blocked by araC. Neither of these
polypeptides appears in infected BJAB cells.
These two polypeptides may represent different
subsets of the intermediate proteins.
The 15 late polypeptides are initially detected
at 12 h after infection (6) and show maximum
synthesis in 24 h. Three of these polypeptides
are immunoprecipitated by EA+/VCA+ sera.
None is synthesized in EBV-infected BJAB cells
(Feighny et al., submitted for publication).
The persistent class of proteins, 10 polypep-
tides found in Raji cells before infection and
synthesized throughout infection (6), is difficult
to characterize since polypeptides are not im-
munoprecipitated. This class is identified pri-
marily by lack of shutoff of their synthesis after
infection. Some polypeptides which are induced
by superinfection may comigrate with preexist-
ing polypeptides; however, the persistent class
does not seems to include any of the polypep-
tides that are oversynthesized or blocked by the
effects of DNA replication inhibitors. Although
we have not examined this class in detail here,
it may become possible to discern subsets of the
persistent polypeptides as those that are virus
coded and those that are host coded; some may
show increased synthesis after infection, and the
synthesis of others may be maintained at the
same level.
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An additional class of polypeptides appears
initially at 16 h postinfection and becomes most
evident at 36 h. This class of very late polypep-
tides may be related to cell death and lysis.
Alternatively, these proteins may be late pro-
teins which are detected only after the longer
exposure times used. Polypeptides in this class
have not been reported previously. The appear-
ance of this class is apparently unaffected by
DNA inhibitors.
Relatively few EBV-induced polypeptides are
dependent on viral DNA synthesis. The synthe-
sis of only 6 of the 40 detectable polypeptides is
clearly inhibited by ACV and PAA; 5 of these
are late, and 1 is intermediate. Therefore, the
input genome is capable of providing most of the
RNA needed for the translation of EBV-induced
proteins. Accordingly, the classification of poly-
peptides as "late" is not necessarily related to
viral DNA synthesis, in contrast to the synthesis
of late proteins in simian virus 40- or adenovirus-
infected cells. Therefore, the late class includes
polypeptides both dependent and independent
of viral DNA replication. In herpes simplex vi-
rus-infected cells both relations have been pro-
posed, with some reports favoring independent
regulation of synthesis (9, 10) and others stating
that viral DNA replication is essential (8, 25).
The latter mechanism reportedly operates in
cytomegalovirus-induced protein synthesis (22).
These studies, using a range of inhibitors,
demonstrate that the use of a single inhibitor
such as araC (17) and the analysis of polypeptide
synthesis at single time points in EBV-infected
cells may lead to oversimplifications. Polypep-
tides that are not affected at one point may be
inhibited later; for example, 3 and 11 are not
affected at the time of maximum synthesis (11
h), whereas they do not appear at 24 h in the
presence of ACV and PAA.
Immunoprecipitation is of obvious utility in
determining the viral nature of some of the
newly synthesized polypeptides; however, there
are some disadvantages to this method. First,
although extracts of mock-infected and super-
infected cells were preabsorbed with EA-/VCA-
serum, reducing significantly the amount of
background radioactivity precipitated from un-
infected Raji cells (data not shown), there re-
main a number of polypeptides that are precip-
itated from the mock-infected extracts. These
polypeptides may be non-specifically trapped
despite numerous rinses. They may share anti-
genic determinants with the virus-induced poly-
peptides. They may be host proteins that are
normally not antigenic, but which are exposed
and become antigenic during acute infection or
in patients with Burkitt's lymphoma and naso-
pharyngeal carcinomas. Finally, they may be
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virus-coded polypeptides preexisting in Raji cells
inasmuch as these cells already bear latent EBV
genomes and express at least one viral product,
Epstein-Barr nuclear antigen.
Another disadvantage is that nonstructural
viral proteins may be missed which have impor-
tant functions, including enzymatic functions,
but which are weakly antigenic. The three im-
mediate-early polypeptides are not immunopre-
cipitated with EA+/VCA+ antisera, perhaps be-
cause they appear very early before cell lysis and
may not be expressed outside of the cell. The
small number of late polypeptides which can be
immunoprecipitated (only 3 of 15) may be re-
lated to the abortive nature of the superinfection
system.
The mechanisms causing the oversynthesis of
the immediate-early and several of the early
polypeptides in the presence of araC, araA, and
MTX are not clear. This oversynthesis does not
appear to be caused by blockage of viral DNA
replication since the virus-specific inhibitors
ACV and PAA do not cause a similar phenom-
enon. Nor does the prolonged synthesis appear
to be related to drug effects on translation or
transcription since the majority of virus-induced
polypeptides are synthesized normally. The time
of appearance of these polypeptides is not
changed, and the transitions to early, interme-
diate, and late protein synthesis occur normally.
Shutoff of host protein synthesis is not affected.
A possible mechanism may involve transcription
of the episomal EBV DNA. This DNA, which
apparently replicates by the use of host enzymes
(4), may express some virally coded regulatory
polypeptides of the persistent class. These reg-
ulatory proteins may be essential for prevention
of continued synthesis of the immediate-early
and early polypeptides. Alternatively, the pro-
teins may be regulated by a feedback mechanism
which is functional only in the presence of cer-
tain concentrations of specific polypeptides. In
the cells treated with araC, araA, and MTX such
a feedback system may be interrupted and func-
tion at a late time. It should be emphasized,
however, that whether episomal genes are ex-
pressed remains unknown (18).
The inhibitors FUdR and NVB did not sig-
nificantly affect viral DNA replication. There
was some inhibition ofprotein synthesis by these
drugs; however, the patterns were not similar to
those produced by the other inhibitors. FUdR
does not interfere with virus DNA replication
and is reported to cause increased viral DNA
synthesis in 12-O-tetradecanoyl-phorbol-13-ace-
tate-treated P3HR-1 cells (28). We have con-
firmed that in superinfected cells the effect of
FUdR on virus DNA replication is stimulatory
at higher concentrations of the drug (B. E.
J. VIROL.
Henry II, R. J. Feighny, and J. S. Pagano, man-
uscript in preparation). At the concentration
used here the polypeptide patterns ofthe FUdR-
treated infected cells are similar throughout in-
fection. NVB does not inhibit virus DNA syn-
thesis significantly (Table 3). The suspected
mode of action in procaryotes is that NVB af-
fects DNA gyrase (5), inhibiting supercoiling of
DNA. If this mechanism operates also in eucar-
yotic cells, then transcripts for most polypep-
tides will arise before the terminal events of
DNA replication.
The results reported here are the first example
of the differential effects of DNA inhibitors on
viral polypeptide synthesis. The oversynthesis
of certain polypeptides in the presence of araC
is so far unique to EBV. There is an increase in
the rate of synthesis of certain polypeptides
when cycloheximide is used in herpes simplex
virus-infected cells; however araC does not cause
the same effect (10). In cytomegalovirus systems
araC apparently does not lead to prolonged syn-
thesis of any polypeptides (22, 23). Regulation
of polypeptide synthesis may be similar to that
in herpes simplex virus-infected cells in which a
cascade mechanism for synthesis of different
classes operates. In addition, although viral
DNA replication is not needed for the synthesis
of most of the EBV-induced polypeptides, it is
required for efficient expression of all the late
genes.
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